Short-Term Efficacy of Botulinum Toxin A for Refractory Overactive Bladder in the Elderly Population

Journal of Urology

Volumn 180, Issue 6, 2008, Pages 2522-2526

  White, Wesley M ^a   Pickens, Ryan B ^a   Doggweiler, Regula ^a   Klein, Frederick A ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

aged; botulinum toxin type A; injections; overactive; urinary bladder; urinary incontinence

Indexed keywords

BOTULINUM TOXIN A; CHOLINERGIC RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR BLOCKING AGENT;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYSTOSCOPY; DRUG EFFICACY; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MALE; OVERACTIVE BLADDER; PRIORITY JOURNAL; URINARY URGENCY; URODYNAMICS;

AGED; AGED, 80 AND OVER; BOTULINUM TOXIN TYPE A; FEMALE; HUMANS; MALE; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; TIME FACTORS; URINARY BLADDER, OVERACTIVE;

EID: 55549113878     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2008.08.030     Document Type: Article

References (17)

1. Payne C.K. Behavioral therapy for overactive bladder. Urology 55 (2000) 3
2. Ouslander J.G. Management of overactive bladder. N Engl J Med 350 (2004) 786
3. Chu F.M., Dmochowski R.R., Lama D.J., Anderson R.U., and Sand P.K. Extended-release formulations of oxybutynin and tolterodine exhibit similar central nervous system tolerability profiles: a subanalysis of data from the OPERA trial. Am J Obstet Gynecol 192 (2005) 1849
4. Vasavada S.P., and Rackley R.R. Electrical stimulation for storage and emptying disorders. In: Kavoussi L.R., Novick A.C., Partin A.W., Peters C.A., and Wein A.J. (Eds). Campbell-Walsh Urology. 9th ed (2007), WB Saunders, Philadelphia 2147-2167 vol 3, chapt 64
5. Schurch B., Stohrer M., Kramer G., Schmid D.M., Gaul G., and Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol 164 (2000) 692
6. Schmid D.M., Sauermann M., Werner B., Schuessler N., Blick N., Muentener M., et al. Experience with 100 cases treated with botulinum-A toxin injection in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics. J Urol 176 (2006) 177
7. Kuo H.C. Comparison of effectiveness of detrusor, suburothelial, and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity. J Urol 178 (2007) 1359
8. Schurch B, Hauri D, Rodic B, Curt A, Meyer M and Rossier AB: Botulinum-A toxin as a treatment of detrusor-sphincter dyssynergia: a prospective study in 24 spinal cord injury patients.
9. Schurch B., de Seze M., Denys P., Chartier-Kastler E., Haab F., Everaert K., et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 174 (2005) 196
10. Smith C.P., Nishiguchi J., O'Leary M., Yoshimura N., and Chancellor M.B. Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology 65 (2005) 37
11. Reitz A., Denys P., Fermanian C., Schurch B., Comperat E., and Chartier-Kastler E. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol 52 (2007) 1729
12. Del Popolo G., Filocamo M.T., Li Marzi V., Macchiarella A., Cecconi F., Lombardi G., et al. Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre. Eur Urol 53 (2008) 1013
13. Dmochowski R.R., and Sand P.K. Botulinum toxin A in the overactive bladder: current status and future directions. BJU Int 99 (2007) 247
14. Schurch B. Botulinum toxin for the management of bladder dysfunction. Drugs 66 (2006) 1301
15. Kalsi V., Gonzales G., Popat R., Apostolidis A., Elneil S., Dasgupta P., and Fowler C.J. Botulinum injections for the treatment of bladder symptoms of multiple sclerosis. Ann Neurol 62 (2007) 452
16. Jeffery S., Fynes M., Lee F., Wang K., Williams L., and Morley R. Efficacy and complications of intradetrusor injection with botulinum toxin A in patients with refractory idiopathic detrusor overactivity. BJU Int 100 (2007) 1302
17. Schurch B., Denys P., Kozma C.M., Reese P.R., Slaton T., and Barron R.L. Botulinum toxin A improves quality of life of patients with neurogenic urinary incontinence. Eur Urol 52 (2007) 850